Plasma Fractionation Market: By Product Type (Albumin, Immunoglobulin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Fractionation Products), By Application (Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology and Others), By End Users (Hospitals, Clinics, Academic Institutes and Clinical Research Laboratories) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Plasma Fractionation Market size was valued at USD 26,8 billion in 2022 and is projected to reach USD 40.2 billion by 2029, growing at a CAGR of 6.8% during the forecast period 2023 to 2029. plasma fractionation is a vital medical process used to separate the components of blood plasma, the liquid part of blood. This process is crucial for producing various blood-derived medical products. It starts with collecting whole blood from donors, which is then spun in a centrifuge to separate its components: red blood cells, white blood cells, platelets, and plasma. Plasma, making up about 55% of blood volume, plasma undergoes fractionation to break it down into key protein components like albumin, immunoglobulins (antibodies), and clotting factors. These components are meticulously purified to meet strict safety and quality standards. Once purified, they can be formulated into medical products such as clotting factor concentrates for hemophilia, immune globulins for immunodeficiency disorders, and albumin for fluid replacement therapy. is the focus. key drivers fueling the growth of the plasma fractionation market are the Increasing demand for plasma-derived therapies to treat various medical conditions, A rising aging population with age-related diseases that require plasma-derived products, Ongoing advancements in medical science expanding the applications of these products, Increased awareness through healthcare campaigns, leading to greater demand. In the global plasma fractionation market, various segments cater to different medical specialties and applications. These segments include Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology, and others. Among these, the Neurology segment is anticipated to experience the fastest-growing market during the forecast period from 2023 to 2029. The growth of the Neurology segment suggests an increasing demand for plasma-derived products in the field of neurology, possibly for the treatment of neurological disorders and conditions. This could be due to advancements in therapeutic options and the expanding role of plasma-derived therapies in addressing neurological diseases.

Plasma Fractionation Market Key Developments :

  • In Aug 2022, CSL Plasma reimagines donor experience with first donations completed on innovative plasma collection technology.
  • In May 2022, CSL Behring's Biologics License got approval from FDA for Etranacogene Dezaparvovec for Priority Review.  

Global Plasma Fractionation Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Plasma Fractionation Market Dynamics

The plasma fractionation market is experiencing significant growth, and several key drivers are fueling this expansion:

  1. Increasing demand for plasma-derived therapies to treat various medical conditions.
  2. A rising aging population with age-related diseases that require plasma-derived products.
  3. Ongoing advancements in medical science expanding the applications of these products.
  4. Increased awareness through healthcare campaigns, leading to greater demand.
  5. Expanding healthcare infrastructure and rising expenditure in emerging markets, 

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Plasma Fractionation Market Segmentation

By Product Type
  • Albumin
  • Immunoglobulin
  • Coagulation Factor Concentrates
  • Protease Inhibitors
  • Other Plasma Fractionation Products
By Application
  • Neurology
  • Haematology
  • Immunology
  • Rheumatology
  • Haemato-oncology
  • Critical Care
  • Pulmonology
  • Others
By End User
  • Hospitals
  • Clinics
  • Academic Institutes
  • Clinical Research Laboratories

Frequently Asked Questions

The fastest-growing segment of the global plasma fractionation market is Immunoglobulin due to its various applications.          

Rising prevalence of bleeding disorders will create lucrative opportunity in the global market due to major applications of plasma fractionation products.

Collaborations and new product launches and investment in R&D sector are the main strategies of the global players to establish in the market.

Decreasing supply of plasma due to low donor turnout may hamper the global market growth at a significant rate.

1. Executive summary

2. Global Plasma Fractionation Market Introduction

      2.1. Global Plasma Fractionation Market - Taxonomy
      2.2. Global Plasma Fractionation Market - Definitions
            2.2.1. Product Type
            2.2.2. End User
3. Global Plasma Fractionation Market Dynamics
      3.1. Drivers
      3.2. Restraints
      3.3. Opportunities/Unmet Needs of the Market
      3.4. Trends
      3.5. Global Plasma Fractionation Market Dynamics - Factors Impact Analysis
      3.6. Global Plasma Fractionation Market- Regulations
            3.6.1. U.S
            3.6.2. Europe
            3.6.3. Japan
4. Global Plasma Fractionation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      4.3. Market Oppurtunity Analysis
5. Global Plasma Fractionation Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029
      5.1. Albumin
            5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.1.3. Market Opportunity Analysis
      5.2. Immunoglobulins
            5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.2.3. Market Opportunity Analysis
      5.3. Coagulation factor concentrates
            5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.3.3. Market Opportunity Analysis
      5.4. Protease inhibitors
            5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.4.3. Market Opportunity Analysis
      5.5. Other Plasma Fractionation Products
            5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.5.3. Market Opportunity Analysis
6. Global Plasma Fractionation Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029
      6.1. Neurology
            6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.1.3. Market Opportunity Analysis
      6.2. Hematology
            6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.2.3. Market Opportunity Analysis
      6.3. Immunology
            6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.3.3. Market Opportunity Analysis
      6.4. Rheumatology
            6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.4.3. Market Opportunity Analysis
      6.5. Haemato-oncology
            6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.5.3. Market Opportunity Analysis
      6.6. Critical Care
            6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.6.3. Market Opportunity Analysis
      6.7. Pulmonology
            6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.7.3. Market Opportunity Analysis
      6.8. Others
            6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.8.3. Market Opportunity Analysis
7. Global Plasma Fractionation Market Forecast, By End user, 2018 - 2022 and Forecast, 2023 - 2029
      7.1. Hospitals
            7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.1.3. Market Opportunity Analysis
      7.2. Clinics
            7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.2.3. Market Opportunity Analysis
      7.3. Academic Institutes
            7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.3.3. Market Opportunity Analysis
      7.4. Clinical Research Laboratories
            7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.4.3. Market Opportunity Analysis
8. Global Plasma Fractionation Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
      8.1. North America
            8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.1.3. Market Opportunity Analysis
      8.2. Europe
            8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.2.3. Market Opportunity Analysis
      8.3. Asia-Pacific
            8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.3.3. Market Opportunity Analysis
      8.4. Latin America
            8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.4.3. Market Opportunity Analysis
      8.5. Middle East and Africa
            8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.5.3. Market Opportunity Analysis
      8.6. Global Plasma Fractionation Market- Opportunity Analysis Index - By Product Type, By Application, By End user, and Region, 2023 - 2029
9. North America Plasma Fractionation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      9.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            9.1.1. Albumin
            9.1.2. Immunoglobulin
                    9.1.2.1. Intravenous immunoglobulin
                    9.1.2.2. Subcutaneous immunoglobulin
                    9.1.2.3. Others
            9.1.3. Coagulation Factor Concentrates
                    9.1.3.1. Factor viii
                    9.1.3.2. Factor ix
                    9.1.3.3. Factor xiii
                    9.1.3.4. Prothrombin complex concentrates
                    9.1.3.5. Von Willebrand factor (VWF)
            9.1.4. Protease Inhibitors
            9.1.5. Other Plasma Fractionation Products
      9.2. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.2.1. Neurology
            9.2.2. Hematology
            9.2.3. Immunology
            9.2.4. Rheumatology
            9.2.5. Haemato-oncology
            9.2.6. Critical Care
            9.2.7. Pulmonology
            9.2.8. Others
      9.3. End user Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.3.1. Hospitals
            9.3.2. Clinics
            9.3.3. Academic Institutes
            9.3.4. Clinical Research Laboratories
      9.4. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            9.4.1. U.S.
            9.4.2. Canada
      9.5. North America Plasma Fractionation Market- Opportunity Analysis Index - By Product Type, By Application, By End user, and Country, 2023 - 2029
      9.6. North America Plasma Fractionation Market Dynamics - Trends
10. Europe Plasma Fractionation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      10.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            10.1.1. Albumin
            10.1.2. Immunoglobulin
                    10.1.2.1. Intravenous immunoglobulin
                    10.1.2.2. Subcutaneous immunoglobulin
                    10.1.2.3. Others
            10.1.3. Coagulation Factor Concentrates
                    10.1.3.1. Factor viii
                    10.1.3.2. Factor ix
                    10.1.3.3. Factor xiii
                    10.1.3.4. Prothrombin complex concentrates
                    10.1.3.5. Von Willebrand factor (VWF)
            10.1.4. Protease Inhibitors
            10.1.5. Other Plasma Fractionation Products
      10.2. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.2.1. Neurology
            10.2.2. Hematology
            10.2.3. Immunology
            10.2.4. Rheumatology
            10.2.5. Haemato-oncology
            10.2.6. Critical Care
            10.2.7. Pulmonology
            10.2.8. Others
      10.3. End user Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.3.1. Hospitals
            10.3.2. Clinics
            10.3.3. Academic Institutes
            10.3.4. Clinical Research Laboratories
      10.4. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.4.1. Germany
            10.4.2. UK
            10.4.3. France
            10.4.4. Spain
            10.4.5. Italy
            10.4.6. Russia
            10.4.7. Poland
            10.4.8. Rest of Europe
      10.5. Europe Plasma Fractionation Market- Opportunity Analysis Index - By Product Type, By Application, By End user Type, and Country, 2023 - 2029
      10.6. Europe Plasma Fractionation Market Dynamics - Trends
11. Asia-Pacific Plasma Fractionation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      11.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            11.1.1. Albumin
            11.1.2. Immunoglobulin
                    11.1.2.1. Intravenous immunoglobulin
                    11.1.2.2. Subcutaneous immunoglobulin
                    11.1.2.3. Others
            11.1.3. Coagulation Factor Concentrates
                    11.1.3.1. Factor viii
                    11.1.3.2. Factor ix
                    11.1.3.3. Factor xiii
                    11.1.3.4. Prothrombin complex concentrates
                    11.1.3.5. Von Willebrand factor (VWF)
            11.1.4. Protease Inhibitors
            11.1.5. Other Plasma Fractionation Products
      11.2. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.2.1. Neurology
            11.2.2. Hematology
            11.2.3. Immunology
            11.2.4. Rheumatology
            11.2.5. Haemato-oncology
            11.2.6. Critical Care
            11.2.7. Pulmonology
            11.2.8. Others
      11.3. End user Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.3.1. Hospitals
            11.3.2. Clinics
            11.3.3. Academic Institutes
            11.3.4. Clinical Research Laboratories
      11.4. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            11.4.1. Japan
            11.4.2. China
            11.4.3. India
            11.4.4. ASEAN
            11.4.5. Australia & New Zealand
            11.4.6. Rest of Asia-Pacific
      11.5. Asia-Pacific Plasma Fractionation Market- Opportunity Analysis Index - By Product Type, By Application, By End user Type, and Country, 2023 - 2029
      11.6. Asia-Pacific Plasma Fractionation Market Dynamics - Trends
12. Latin America Plasma Fractionation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      12.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            12.1.1. Albumin
            12.1.2. Immunoglobulin
                    12.1.2.1. Intravenous immunoglobulin
                    12.1.2.2. Subcutaneous immunoglobulin
                    12.1.2.3. Others
            12.1.3. Coagulation Factor Concentrates
                    12.1.3.1. Factor viii
                    12.1.3.2. Factor ix
                    12.1.3.3. Factor xiii
                    12.1.3.4. Prothrombin complex concentrates
                    12.1.3.5. Von Willebrand factor (VWF)
            12.1.4. Protease Inhibitors
            12.1.5. Other Plasma Fractionation Products
      12.2. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.2.1. Neurology
            12.2.2. Hematology
            12.2.3. Immunology
            12.2.4. Rheumatology
            12.2.5. Haemato-oncology
            12.2.6. Critical Care
            12.2.7. Pulmonology
            12.2.8. Others
      12.3. End user Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.3.1. Hospitals
            12.3.2. Clinics
            12.3.3. Academic Institutes
            12.3.4. Clinical Research Laboratories
      12.4. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.4.1. Brazil
            12.4.2. Mexico
            12.4.3. Argentina
            12.4.4. Venezuela
            12.4.5. Rest of Latin America
      12.5. Latin America Plasma Fractionation Market- Opportunity Analysis Index - By Product Type, By Application, By End user Type, and Country, 2023 - 2029
      12.6. Latin America Plasma Fractionation Market Dynamics - Trends
13. Middle East & Africa Plasma Fractionation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      13.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            13.1.1. Albumin
            13.1.2. Immunoglobulin
                    13.1.2.1. Intravenous immunoglobulin
                    13.1.2.2. Subcutaneous immunoglobulin
                    13.1.2.3. Others
            13.1.3. Coagulation Factor Concentrates
                    13.1.3.1. Factor viii
                    13.1.3.2. Factor ix
                    13.1.3.3. Factor xiii
                    13.1.3.4. Prothrombin complex concentrates
                    13.1.3.5. Von Willebrand factor (VWF)
            13.1.4. Protease Inhibitors
            13.1.5. Other Plasma Fractionation Products
      13.2. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            13.2.1. Neurology
            13.2.2. Hematology
            13.2.3. Immunology
            13.2.4. Rheumatology
            13.2.5. Haemato-oncology
            13.2.6. Critical Care
            13.2.7. Pulmonology
            13.2.8. Others
      13.3. End user Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            13.3.1. Hospitals
            13.3.2. Clinics
            13.3.3. Academic Institutes
            13.3.4. Clinical Research Laboratories
      13.4. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            13.4.1. Gulf Cooperation Council (GCC) Countries
            13.4.2. Israel
            13.4.3. South Africa
            13.4.4. Rest of MEA
      13.5. MEA Plasma Fractionation Market- Opportunity Analysis Index - By Product Type, By Application, By End user, and Country, 2023 - 2029
      13.6. MEA Plasma Fractionation Market Dynamics - Trends
14. Competition Landscape
      14.1. Strategic Dashboard of Top Market Players
      14.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
            14.2.1. Grifols S.A (Spain)
            14.2.2. CSL Ltd. (Australia)
            14.2.3. Shire (Ireland)
            14.2.4. Octapharma AG (Switzerland)
            14.2.5. Kedrion S.p.A (Italy)
            14.2.6. China Biologic Products, Inc. (China)
            14.2.7. Biotest AG (OGEL GmbH) (Germany)
            14.2.8. LFB S.A (France)
            14.2.9. Sanquin (Netherlands)
15. Research Methodology
16. Key Assumptions and Acronyms
  • Grifols S.A (Spain)
  • CSL Ltd. (Australia)
  • Shire (Ireland
  • Octapharma AG (Switzerland)
  • Kedrion S.p.A (Italy)
  • China Biologic Products, Inc. (China)
  • Biotest AG (OGEL GmbH) (Germany)
  • LFB S.A (France)
  • Sanquin (Netherlands)

Adjacent Markets